AdvisorNet Financial, Inc
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1409362
MINNETONKA, MN
Position in REGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$136,555
+$32,249 QoQ
Shares Held
219
+62.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,077
of 1,327 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AdvisorNet Financial, Inc holds $3,788,127 across 40 Biotechnology names. REGN ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,349 | $1,663,548 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
8,503 | $463,753 | |
| 3 | INCY |
Incyte Corp
|
3,022 | $342,573 | |
| 4 | NAMS |
NewAmsterdam Pharma Co N.V.
|
8,375 | $283,828 | |
| 5 | TECH |
BIO-TECHNE Corp
|
3,051 | $215,553 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
219 | $136,555 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
524 | $98,134 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
1,620 | $89,002 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $136,555 | 219 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $104,306 | 135 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $40,137 | 52 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $34,860 | 62 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $32,025 | 61 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $47,567 | 75 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $55,561 | 78 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $105,124 | 100 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $72,521 | 69 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $66,411 | 69 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $90,463 | 103 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $101,224 | 123 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $175,323 | 244 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $210,347 | 256 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $183,979 | 255 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $161,195 | 234 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $141,280 | 239 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $81,715 | 117 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $82,097 | 130 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $77,463 | 128 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $70,934 | 127 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $68,132 | 144 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $77,297 | 160 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $112,515 | 201 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $109,762 | 176 | Shares | Sole | 2020-08-26 | |
| 2020-03-31 | $49,317 | 101 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||